Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:protein
|
| gptkbp:alternativeName |
dalantercept
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Acceleron_Pharma
|
| gptkbp:hasComponent |
Fc region of IgG
ALK1 extracellular domain |
| https://www.w3.org/2000/01/rdf-schema#label |
ALK1-Fc
|
| gptkbp:inhibitedBy |
gptkb:BMP9
gptkb:BMP10 |
| gptkbp:investigatedBy |
gptkb:cancer
anti-angiogenesis |
| gptkbp:mechanismOfAction |
ligand trap
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:target |
solid tumors
renal cell carcinoma ALK1 receptor pathway |
| gptkbp:bfsParent |
gptkb:BMP9
|
| gptkbp:bfsLayer |
7
|